Technology News and Research

RSS

Creabilis receives $20 million in Series B funding

Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, inflammation and pain, has raised €15 million ($20 million) in a Series B funding round led by Abbott Biotech Ventures.

4 Oct 2011

Complete Genomics, Scripps collaborate to unlock genetic secrets of lifelong health

Complete Genomics Inc., the whole human genome sequencing company, and the not-for-profit Scripps Health system today announced a major collaboration that will help further the Wellderly Study, a landmark scientific research initiative aimed at unlocking the genetic secrets of lifelong health.

4 Oct 2011

Cancer patients prefer to use Web-based technology for quality of life survey

When cancer patients are given the choice, they are significantly more likely to use Web-based technology to answer questions about their quality of life six months after treatment, compared to a paper survey, according to a unique study presented at a scientific session, October 5, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.

4 Oct 2011

TAU researcher implants robotic cerebellum to repair motor function

With new cutting-edge technology aimed at providing amputees with robotic limbs, a Tel Aviv University researcher has successfully implanted a robotic cerebellum into the skull of a rodent with brain damage, restoring its capacity for movement.

4 Oct 2011

TriLogic, Mission Pharmacal partner to develop new drug delivery system

Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.

4 Oct 2011

Adaptimmune announces new board appointments as clinical programmes get underway

Adaptimmune, the T cell therapy company pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune’s Chief Operating Officer, becomes an executive director.

3 Oct 2011

IMRIS unveils VISIUS Surgical Theatre

IMRIS Inc. today officially launched VISIUS Surgical Theatre, its new global product branding at the Congress of Neurological Surgeons (CNS) being held in Washington DC.

3 Oct 2011

USAID awards ICF International $21.5M contract for LEAD program

ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has won a new contract with the U.S. Agency for International Development (USAID) Regional Development Mission for Asia to support the Low Emissions Asian Development (LEAD) program. The contract has a value of $21.5 million and a term of five years.

3 Oct 2011

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

Florida AHCA renews Medicaid Management Information System service agreement with HP

HP Enterprise Services today announced the Florida Agency for Health Care Administration (AHCA) has signed a renewal service agreement to manage the state's Medicaid Management Information System.

3 Oct 2011

HealthPort is the first HIH to transmit records via CMS' esMD gateway

HealthPort, the industry authority on the HIPAA-compliant exchange of protected health information through release of information services and audit management technology, today announced that the Company is the first Health Information Handler (HIH) to successfully transmit records via the Centers for Medicare and Medicaid Services' (CMS) electronic submission of medical documentation (esMD) gateway for information exchange from healthcare providers, once again leading the way in release of information innovation.

3 Oct 2011

Scientists discover 16 million SNPs that associate with increased risk of ovarian cancer

Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain and Finland today report the discovery of variants in the human genome that associate with increased risk of invasive ovarian cancer, one of the deadliest forms of cancer in women.

3 Oct 2011

FDA clears Nucletron's new VCMC Applicator for gynecologic cancers

During the first day of the annual conference for the American Society for Radiation Oncology (ASTRO) in Miami, Nucletron, an Elekta company, today announced that it has received FDA 510(k) clearance for its new Vaginal CT/MR Multi Channel (VCMC) Applicator, offering a brachytherapy solution that enables very precise dose delivery for gynecologic cancers.

From Elekta 3 Oct 2011

IBA offers full line of Proton Therapy solutions for cancer specialty centers

IBA Particle Therapy now offers a range of Proton Therapy solutions for cancer specialty centers planning to treat from 250 to 2,000 patients annually with protons.

From Elekta 3 Oct 2011

First clinical implementation of RayStation at MGH

RaySearch Laboratories AB announces that the first cancer patient has been treated using a treatment plan created with RaySearch's treatment planning system RayStation. The treatment was carried out at the Massachusetts General Hospital Radiation Oncology Department.

From Elekta 3 Oct 2011

H.I.M. ON CALL releases AVIANCE DNFB Management solution at AHIMA Convention and Exhibit

H.I.M. ON CALL, a technology and outsourcing services company for health information management, coding and revenue cycle, announced the availability of its latest AVIANCEHealth technology solution, AVIANCE DNFB Management today at the American Health Information Management Association Convention and Exhibit at the Salt Palace Convention Center in Salt Lake City, Utah.

1 Oct 2011

BIO: Advanced biofuels can be commercialized rapidly for military use

Advanced biofuels can be commercialized rapidly for military use, on military timelines, with adequate support and coordination of efforts by the U.S. Departments of Agriculture, Defense and Energy.

1 Oct 2011

Subsidiary Acacia Research receives patents for heart valve technology

Acacia Research Corporation announced today that a subsidiary has acquired patents for heart valve technology from a major medical device company.

1 Oct 2011

Tomosynthesis offers women the next generation in breast cancer detection

Breast cancer is the second most common type of cancer among women in the United States, with approximately 200,000 new diagnoses each year. Early detection is key in the treatment of breast cancer and the biggest advancement for detection in 30 years has arrived at University Hospitals Case Medical Center - tomosynthesis, an innovative technology that provides three-dimensional detailed imaging of the breast.

1 Oct 2011

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

1 Oct 2011